<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pathogenesis of EBV+ Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) suggests evasion of the CTL response against EBV </plain></SENT>
<SENT sid="1" pm="."><plain>Two important features of this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> have been previously suggested to explain this immune evasion, (a) absence/low expression of cellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules and (b) restricted expression of EBV latent Ag </plain></SENT>
<SENT sid="2" pm="."><plain>To determine the relative importance of these features in relation to evasion of EBV-specific CTL, a group of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines with variable expression of the aforementioned phenotypic characteristics were assayed for specific CTL lysis after exogenous addition of EBV <z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="53000">epitopes</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In spite of down-regulated expression of the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules LFA-1, LFA-3, and/or ICAM-1, <z:chebi fb="7" ids="16670">peptide</z:chebi>-sensitized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells were recognized and lysed by EBV-specific CTL </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, there was no significant difference between the CTL lysis of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells and that of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-positive control cells over a wide range of <z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="53000">epitope</z:chebi> concentrations </plain></SENT>
<SENT sid="5" pm="."><plain>Blocking experiments with mAb to individual <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules suggested that virus-specific CTL recognition of lymphoblastoid cell lines was dependent on an intact LFA-3/CD2 pathway </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, the CTL recognition of <z:chebi fb="7" ids="16670">peptide</z:chebi>-sensitized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells was critically dependent on the LFA-1/ICAM pathway, with an insignificant contribution by CD2/LFA-3 </plain></SENT>
<SENT sid="7" pm="."><plain>The consistently high expression of ICAM-2 on <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines suggests that the accessory function in CTL recognition of these cells is mediated by the LFA-1/ICAM-2 pathway </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, down-regulation of LFA-1, LFA-3, and/or ICAM-1 expression on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells does not provide an absolute barrier to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell recognition by virus-specific CTL </plain></SENT>
<SENT sid="9" pm="."><plain>The ability of virus-specific CTL to recognize <z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="53000">epitope</z:chebi>-sensitized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells as efficiently as <z:mpath ids='MPATH_458'>normal</z:mpath> cells has demonstrated the importance of latent Ag expression in the CTL control of EBV+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>